GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Construction In Progress

Labiana Health (XMAD:LAB) Construction In Progress : €2.45 Mil (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Construction In Progress?

Labiana Health's quarterly construction in progress increased from Dec. 2021 (€1.15 Mil) to Jun. 2022 (€1.62 Mil) and increased from Jun. 2022 (€1.62 Mil) to Dec. 2022 (€2.45 Mil).

Labiana Health's annual construction in progress increased from Dec. 2020 (€1.08 Mil) to Dec. 2021 (€1.15 Mil) and increased from Dec. 2021 (€1.15 Mil) to Dec. 2022 (€2.45 Mil).

Labiana Health Construction In Progress Historical Data

The historical data trend for Labiana Health's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Construction In Progress Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Construction In Progress
1.08 1.15 2.45

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Construction In Progress 1.08 1.15 1.62 2.45

Labiana Health Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Labiana Health (XMAD:LAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Construction In Progress
Comparable Companies
BOM:521141 BOM:531744 BOM:514400 BOM:539546 BOM:514280 BOM:531223 BOM:532140 BOM:514318 BOM:521131 NSE:VCL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Website
https://www.labiana.com
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.